Vida Health
Vida Health sells AI-enabled virtual cardiometabolic and behavioral health care, including obesity, diabetes, hypertension and mental health, to employers and health plans.
Vida Health, founded in 2014, runs a virtual care platform that pairs AI-driven personalization and device data (CGMs, scales, trackers) with human coaches, dietitians, therapists and prescribers. It sells mainly to employers, health plans and providers, and puts a share of its fees at risk against outcomes. In 2025 it raised a $35M Series F. Data aggregators put its total funding at roughly $217–252M, its revenue at about $108–111M, and its headcount at roughly 600–680 (2026). In 2026 it launched Vida Self-Pay for GLP-1 and other anti-obesity medications and earned the DiMe Seal.
